Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers

NCT01334697 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: recombinant human cardiotrophin-1
OTHER: Placebo

Sponsor

Digna Biotech S.L.